Guggenheim S&P 500® Eq Weight HC ETF

Most Recent

  • uploads///Chart
    Company & Industry Overviews

    Estimates and Recommendations for DaVita on September 17

    Analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017.

    By Mike Benson
  • uploads///doctor _
    Company & Industry Overviews

    Allergan Unveils Spotlyte, Its First Digital Ventures Launch

    On September 12, Allergan (AGN) announced the launch of Spotlyte, the first launch from Project Moonwalker, the Allergan-owned digital ventures unit.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    Thermo Fisher to Acquire BDX’s Advanced Bioprocessing Business

    Thermo Fisher Scientific (TMO) announced on September 7, 2018, that the company would acquire the Advanced Bioprocessing Business from Becton Dickinson (BDX).

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    Changes in Bristol-Myers Squibb’s Profitability in 2016

    Bristol-Myers Squibb (BMY) reported a rise of 17% in revenue to ~$19.4 billion in 2016, compared to $16.6 billion in 2015. The company reported a net profit of ~$4.5 million in 2016.

    By Mike Benson
  • uploads///VALUATION
    Earnings Report

    A Look at Johnson & Johnson’s Valuation ahead of Its 2Q16 Results

    Due to Johnson & Johnson’s wide geographic presence, expansive product portfolio, and strong cash flow, its valuation multiple has witnessed a gradual rise.

    By Sarah Collins
  • uploads///geographical profile
    Company & Industry Overviews

    Mapping Varian Medical Systems’ Geographic Strategy

    Varian Medical Systems (VAR) is a global medical device company that generates ~50% of its total revenues from North America and 26% and 24% of total revenues from Europe and Asia, respectively.

    By Sarah Collins
  • uploads///VALUATION
    Earnings Report

    What Is Medtronic’s Valuation ahead of 4Q16 Results?

    Due to Medtronic’s strong fundamentals, the company’s valuation multiple has witnessed a gradual rise since its 3Q16 earnings release.

    By Sarah Collins
  • uploads///strategic initiatives
    Company & Industry Overviews

    How Baxter’s Biosciences Spin-off into Baxalta Improved Its Valuation

    On July 1, 2015, Baxter separated its Biosciences division into a new entity named Baxalta in an effort to divest risky segments and streamline operations.

    By Sarah Collins
  • uploads///geographic segmentation
    Company & Industry Overviews

    The Geographic Strategy of Thermo Fisher Scientific

    Thermo Fisher Scientific is a global company, but the majority of its revenues are generated from the developed markets. The US is its largest market, generating ~48% of the company’s total revenues.

    By Sarah Collins
  • uploads///geographic segmentation
    Company & Industry Overviews

    Mapping Abbott Laboratories’ Geographic Strategy

    Abbott Laboratories is a global healthcare company that sees 70% of its total revenues generated in markets outside the United States.

    By Sarah Collins
  • uploads///global footprint
    Company & Industry Overviews

    Analyzing Becton, Dickinson and Company’s Geographic Strategy

    Becton, Dickinson and Company (BDX), or BD, has operations across the globe, with more than 50% of its 2015 revenues coming from international markets.

    By Sarah Collins
  • uploads///xray pbv
    Earnings Report

    How Does Dentsply International Compare to Peers after 3Q15?

    In this article, we’ll compare Dentsply against its peers and the ETFs that invest in Dentsply.

    By Gabriel Kane
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.